Brush-based self-sampling in combination with GP5+/6+-PCR-based hrHPV testing: High concordance with physician-taken cervical scrapes for HPV genotyping and detection of high-grade CIN

被引:39
作者
Dijkstra, Maaike G. [1 ]
Heideman, Danielle A. M. [1 ]
van Kemenade, Folkert J. [1 ]
Hogewoning, Kees J. A. [2 ]
Hesselink, Albertus T. [1 ]
Verkuijten, Muriel C. G. T. [3 ]
van Baal, W. Marchien [4 ]
Nieuwenhuyzen-de Boer, Gatske M. [5 ]
Snijders, Peter J. F. [1 ]
Meijer, Chris J. L. M. [1 ]
机构
[1] Vrije Univ Amsterdam Med Ctr, Dept Pathol, NL-1007 MB Amsterdam, Netherlands
[2] Albert Schweitzer Ziekenhuis, Dept Obstet & Gynaecol, NL-3318 AT Dordrecht, Netherlands
[3] Radboud Univ Nijmegen Med Ctr, Dept Pathol, NL-6500 HB Nijmegen, Netherlands
[4] Flevoziekenhuis, Dept Obstet & Gynaecol, NL-1300 EG Almere, Netherlands
[5] Reinier Graaf Grp, Dept Obstet & Gynaecol, NL-2600 GA Delft, Netherlands
关键词
Human papillomavirus; HPV DNA testing; Genotyping; Self-sampling; Cervical intraepithelial neoplasia; Self-sampling device; HUMAN-PAPILLOMAVIRUS DETECTION; COLLECTED VAGINAL SPECIMENS; POLYMERASE-CHAIN-REACTION; HIGH-RISK HPV; CERVICOVAGINAL LAVAGE; POSITIVE WOMEN; ABSOLUTE RISK; DNA TEST; CANCER; CYTOLOGY;
D O I
10.1016/j.jcv.2012.02.022
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Studies have shown that self-sampling for hrHPV testing (HPV self-sampling) is highly acceptable to women, increases screening participation rate, and may therefore further reduce cervical cancer incidence. However, it is important to clinically validate HPV self-sampling procedures for screening purposes. Objectives: Clinical validation of combined brush-based self-sampling with GP5+/6+-PCR EIA for primary cervical screening. In addition, HPV type-specific agreement between sample types and acceptability of brush-based self-sampling were evaluated. Study design: 135 women referred for colposcopy took a self-sample at home prior to vaginal-and cervical sampling by a gynaecologist. All women were biopsied for histology. HPV testing was done by GP5+/6+-PCR EIA, with genotyping by reverse line blotting (RLB). Acceptability of sampling methods was measured with a questionnaire. Results: In this outpatient population, hrHPV test results showed good concordance between self-samples and physician-taken cervical scrapes (86%, k = 0.70), with sensitivities and specificities for CIN2+ that did not differ significantly (93% and 51%, 91% and 51%, respectively (P = 1.0)). The clinical sensitivity of brush-based self-sampling combined with GP5+/6+-PCR EIA hrHPV testing for detection of CIN2+ was non-inferior to that of hrHPV testing on physician-taken cervical samples (P = 0.018). In addition, hrHPV genotyping results were highly concordant between sample types, with almost perfect agreement for HPV16 (k = 0.81) and HPV18 (k = 0.92). Finally, 91% of participants described brush-based self-sampling as easy-to-use. Conclusions: Brush-based self-sampling in combination with GP5+/6+-PCR EIA hrHPV testing is acceptable to women and valid for assessing the risk of CIN2+ in comparison to hrHPV testing on physician-taken scrapes. In addition, there was high concordance of HPV genotyping results. Therefore, this HPV self-sampling procedure may be considered for use in routine cervical screening. (C) 2012 Published by Elsevier B.V.
引用
收藏
页码:147 / 151
页数:5
相关论文
共 48 条
[1]  
[Anonymous], HLTH COUNC NETH PUBL
[2]  
ARATA T, 1978, ACTA CYTOL, V22, P150
[3]   Human papillomavirus testing on self-sampled cervicovaginal brushes: An effective alternative to protect nonresponders in cervical screening programs [J].
Bais, Aagje G. ;
van Kemenade, Folkert J. ;
Berkhof, Johannes ;
Verheijen, Rene H. M. ;
Snijders, Peter J. F. ;
Voorhorst, Feja ;
Babovic, Milena ;
van Ballegooijen, Marjolein ;
Helmerhorst, Theo J. M. ;
Meijer, Chris J. L. M. .
INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (07) :1505-1510
[4]   Prevalence of type-specific human papillomavirus in endoceryical, upper and lower vaginal, perineal and vaginal self-collected specimens: implications for vaginal self-collection [J].
Belinson, Jerome L. ;
Hu, Shangying ;
Niyazi, Mayineur ;
Pretorius, Robert G. ;
Wang, He ;
Wen, Chen ;
Smith, Jennifer S. ;
Li, Jing ;
Taddeo, Frank J. ;
Burchette, Raoul J. ;
Qiao, You-Lin .
INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (05) :1151-1157
[5]   Shanxi Province cervical cancer screening study II: Self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology [J].
Belinson, JL ;
Qiao, YL ;
Pretorius, RG ;
Zhang, WH ;
Rong, SD ;
Huang, MN ;
Zhao, FH ;
Wu, LY ;
Ren, SD ;
Huang, RD ;
Washington, MF ;
Pan, QJ ;
Li, L ;
Fife, D .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2003, 13 (06) :819-826
[6]  
Belinson JL, 2011, INT J CANC MAY
[7]   Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries? [J].
Bhatla, Neerja ;
Dar, Lalit ;
Patro, A. Rajkumar ;
Kumar, Pankaj ;
Kriplani, Alka ;
Gulati, Arti ;
Iyer, Venkateswaran K. ;
Mathur, Sandeep R. ;
Sreenivas, Vishnubhatla ;
Shah, Keerti V. ;
Gravitt, Patti E. .
CANCER EPIDEMIOLOGY, 2009, 33 (06) :446-450
[8]   The role of self-collection devices fog cytology and human papillomavirus DNA testing in cervical cancer screening [J].
Bidus, MA ;
Zahn, CM ;
Maxwell, GL ;
Rodriguez, M ;
Elkas, JC ;
Rose, GS .
CLINICAL OBSTETRICS AND GYNECOLOGY, 2005, 48 (01) :127-132
[9]   Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screening [J].
Bidus, Michael A. ;
Maxwell, G. Larry ;
Kulasingam, Shalini ;
Rose, G. Scott ;
Elkas, John C. ;
Chernofsky, Mildred ;
Myers, Evan R. .
OBSTETRICS AND GYNECOLOGY, 2006, 107 (05) :997-1005
[10]   Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands [J].
Bos, Anita B. ;
Rebolj, Matejka ;
Habbema, J. Dik F. ;
van Ballegooijen, Marjolein .
INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (10) :2372-2375